{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:02:32Z","timestamp":1756339352771,"version":"3.44.0"},"reference-count":4,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Overview of:<\/jats:bold>\nMcIntyre WF, Benz AP, Becher N, <jats:italic>et al<\/jats:italic>. Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA Trials. <jats:italic>Circulation<\/jats:italic> 2024;149:981-88.\n<\/jats:p>","DOI":"10.1136\/dtb.2024.000049","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:20:35Z","timestamp":1723162835000},"page":"147-147","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Direct oral anticoagulants for stroke prevention in device-detected AF"],"prefix":"10.1136","volume":"62","member":"239","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2025082623271916000_62.10.147.1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"2025082623271916000_62.10.147.2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2025082623271916000_62.10.147.3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2025082623271916000_62.10.147.4","unstructured":"Link M . Does device-detected atrial fibrillation lasting <24 hours merit anticoagulation [online]. 2023. Available: https:\/\/www.jwatch.org\/na56818\/2023\/11\/14\/does-device-detected-atrial-fibrillation-lasting-24-hours [Accessed 26 Jul 2024]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2024.000049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:27:31Z","timestamp":1756276051000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2024.000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":4,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,9,25]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/dtb.2024.000049"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2024.000049","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}